Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 28. März 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16326  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 326504  
   
The Impact of Exercise and Diet on Ovarian Cancer Mortality.
Anticancer Res
Micha JP, Bohart R, Goldstein BH.
PMID: 41895759 [PubMed - indexed for MEDLINE]


Impact of Biopsy Diagnostic Methods on the Prognosis of Stage I Endometrioid Cancer.
Anticancer Res
Helms L, Sabiani L, Djemouai S, Rambeaud C, Crochet P, Netter A, Carcopino X, Agostini A.
PMID: 41895743 [PubMed - indexed for MEDLINE]


Co-encapsulated fluorescent magnetic nanoparticles for potential applications in breast cancer therapy: Exploratory in vitro and in vivo studies.
Int J Pharm
Sandu S, Dodi G, Gardikiotis I, Cretu BE, Luca A, Cojocaru FD, Verestiuc L, Pasca SA, Balan V.
PMID: 41895480 [PubMed - as supplied by publisher]


Bone marrow involvement in breast cancer: a retrospective cohort study.
Adv Med Sci
Sigorski D, Wilk M, Michalak M, Pieniuk K, Kozielec Z, Lewandowski T, Lebiedzi.
PMID: 41895475 [PubMed - as supplied by publisher]


Prognostic Value of Circulating Tumor DNA for Minimal Residual Disease Detection in Ovarian Cancer: A Systematic Review and Meta-analysis.
Crit Rev Oncol Hematol
Noronha MM, Gouveia MC, Almeida LFC, Silva LFLD, Nohmi RL, Passos PRC, Filho VOC, Al-Alam O, Saldanha EF, Veneziani AC.
PMID: 41895358 [PubMed - as supplied by publisher]


AI Innovations for Ovarian and Endometrial Cancer Diagnosis: Methodological Challenges and Engineering Roadmap.
Crit Rev Oncol Hematol
Angeline J, Bethanney Janney J, Arvind N.
PMID: 41895354 [PubMed - as supplied by publisher]


In silico discovery of selective TPX2 and BUB1B inhibitors as novel antimitotic agents in breast cancer therapy.
Comput Biol Chem
Jakkula BK, Perugu S.
PMID: 41895167 [PubMed - as supplied by publisher]


Exposure to bisphenol analogues and advanced high-grade serous ovarian cancer survival: An integrative study combining epidemiology and mechanism exploration.
Ecotoxicol Environ Saf
Li YZ, Yang R, Liu BQ, Fang Q, Liu JX, Xing WY, Zheng WR, Gao S, Huang DH, Li XY, Zhao JY, Gong TT, Wu QJ.
PMID: 41895143 [PubMed - as supplied by publisher]


Managing diabetes while undergoing breast cancer treatment: a systematic review of women's experiences of self-care and clinical support.
Diabetes Metab Syndr
Murfet N, Mullan L, Johansen C, Livingston PM, White VM, Rothmann MJ, Rasmussen B.
PMID: 41895065 [PubMed - as supplied by publisher]


Anticancer effects of salidroside on ovarian cancer carcinogenesis and molecular mechanism in mice.
Biomed Pharmacother
Suocheng W, Linglong X, Jingshuang G, Kun Y, Yuan C.
PMID: 41895063 [PubMed - as supplied by publisher]


Solid lipid nanoparticles for targeted drug delivery in breast cancer: Biointerface interactions, therapeutic potential, and translational challenges.
Pathol Res Pract
Thakur A, Sharma R, Devi A.
PMID: 41894954 [PubMed - as supplied by publisher]


Classification of histological types in ovarian cancer using deep learning.
Eur J Obstet Gynecol Reprod Biol
Fukuda K, Sakabe N, Sato S, Hara T, Kobayashi H, Nakaguro M, Karube K, Ikeda K.
PMID: 41894940 [PubMed - as supplied by publisher]


Incidence of pelvic fractures after definitive radiotherapy for cervical cancer: A retrospective multicenter cohort study (The IPFAR study).
PLoS One
Shirakawa S, Nagao S, Yoshio K, Mitsuhashi T, Imafuku N, Yamamoto D, Yorimitsu M, Kodama J, Nagasaka H, Nakanishi Y, Masuyama H.
PMID: 41894353 [PubMed - indexed for MEDLINE]


Molecular subtypes of breast cancer in Libyan women and their clinicopathological associations: A retrospective observational study from eastern Libya.
Medicine (Baltimore)
Mohamed Z, Abdulkarim A, Abdullah AR, Al-Azab M, Baklola M.
PMID: 41894312 [PubMed - indexed for MEDLINE]


The role of Notch signalling and its crosstalk with oestrogen receptor signalling in breast cancer.
Cancer Metastasis Rev
Azadova A, Isayev O, Marco A, Brooke GN.
PMID: 41894035 [PubMed - indexed for MEDLINE]


Delayed Diagnosis of Ovarian Cancer and the Association With Disease Outcomes.
JAMA Netw Open
Chase DM, Abdel-Sayed L.
PMID: 41893851 [PubMed - in process]


Diagnostic Timing and Ovarian Cancer Survival.
JAMA Netw Open
Soppe SE, Kuo TM, Bae-Jump VL, Albright BB, Lyratzopoulos G, Baggett CD, Thompson CA.
PMID: 41893845 [PubMed - indexed for MEDLINE]


Breast Adipose Tissue's Xenobiotics and Fatty Acid Profile-A Preliminary Study in Portuguese Women with Breast Cancer.
Toxics
Sousa S, Paíga P, Araújo B, Coelho F, Castela I, Vasques M, Sampaio C, Duarte M, Correia A, Teixeira D, Pestana D, Faria A, Delerue-Matos C, Ramalhosa MJ, Calhau C, Fernandes Domingues V.
PMID: 41893492 [PubMed]


Indocyanine Green Sentinel Lymph Node Mapping as a Tool for Personalized Surgical Management in Uterine Corpus Cancer: A Single-Center Comparative Study.
J Pers Med
Nowak K, Bek W, Mruga, Borowiec Z, Milnerowicz-Nabzdyk E.
PMID: 41893036 [PubMed]


Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 Inhibitors.
J Pers Med
Poli I, Oliva GR, Mongelli G, Rotondi A, Frescura V, Arcuri G, Garufi G, Pontolillo L, Mastrantoni L, Di Monte E, Maliziola N, Fucile MA, Salvatori F, Mondello R, Palazzo A, Fabi A, Bria E, Tortora G, Orlandi A.
PMID: 41893011 [PubMed]


   
   Artikel 1 - 20 / 326504    Seite 1 von 16326  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1